188 related articles for article (PubMed ID: 11862419)
1. Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes.
Dangles V; Halberstam I; Scardino A; Choppin J; Wertheimer M; Richon S; Quelvennec E; Moirand R; Guillet JG; Kosmatopoulos K; Bellet D; Zeliszewski D
Cancer Immunol Immunother; 2002 Feb; 50(12):673-81. PubMed ID: 11862419
[TBL] [Abstract][Full Text] [Related]
2. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
[TBL] [Abstract][Full Text] [Related]
3. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular mechanisms of human cardiac myocyte injury after transplantation.
Ansari AA; Sundstrom JB; Kanter K; Mayne A; Villinger F; Gravanis MB; Herskowitz A
J Heart Lung Transplant; 1995; 14(1 Pt 1):102-12. PubMed ID: 7727458
[TBL] [Abstract][Full Text] [Related]
5. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
[TBL] [Abstract][Full Text] [Related]
6. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
Schroers R; Huang XF; Hammer J; Zhang J; Chen SY
Cancer Res; 2002 May; 62(9):2600-5. PubMed ID: 11980655
[TBL] [Abstract][Full Text] [Related]
7. A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.
Schultz ES; Lethé B; Cambiaso CL; Van Snick J; Chaux P; Corthals J; Heirman C; Thielemans K; Boon T; van der Bruggen P
Cancer Res; 2000 Nov; 60(22):6272-5. PubMed ID: 11103782
[TBL] [Abstract][Full Text] [Related]
8. Identification of mycobacterial peptide epitopes recognized by CD4+ T cells in association with multiple major histocompatibility complex class II molecules.
Mustafa AS
Nutrition; 1995; 11(5 Suppl):657-60. PubMed ID: 8748245
[TBL] [Abstract][Full Text] [Related]
9. T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.
Gedde-Dahl T; Spurkland A; Fossum B; Wittinghofer A; Thorsby E; Gaudernack G
Eur J Immunol; 1994 Feb; 24(2):410-4. PubMed ID: 7507844
[TBL] [Abstract][Full Text] [Related]
10. Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines.
Mustafa AS; Oftung F; Amoudy HA; Madi NM; Abal AT; Shaban F; Rosen Krands I; Andersen P
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S201-5. PubMed ID: 10875783
[TBL] [Abstract][Full Text] [Related]
11. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N; Nabeta Y; Kondo H; Sahara H; Hirohashi Y; Kashiwagi K; Kanaseki T; Sato Y; Rong S; Hirai I; Kamiguchi K; Tamura Y; Matsuura A; Takahashi S; Torigoe T; Ikeda H
Cancer Chemother Pharmacol; 2000; 46 Suppl():S86-90. PubMed ID: 10950155
[TBL] [Abstract][Full Text] [Related]
12. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
Yuen MH; Macklin KD; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
[TBL] [Abstract][Full Text] [Related]
13. Activation-related differences in HLA class I-bound peptides: presentation of an IL-1 receptor antagonist-derived peptide by activated, but not resting, CD4+ T lymphocytes.
Frumento G; Corradi A; Ferrara GB; Rubartelli A
J Immunol; 1997 Dec; 159(12):5993-9. PubMed ID: 9550397
[TBL] [Abstract][Full Text] [Related]
14. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
Bidart JM; Ozturk M; Bellet DH; Jolivet M; Gras-Masse H; Troalen F; Bohuon CJ; Wands JR
J Immunol; 1985 Jan; 134(1):457-64. PubMed ID: 2578049
[TBL] [Abstract][Full Text] [Related]
15. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.
Cammarota G; Scheirle A; Takacs B; Doran DM; Knorr R; Bannwarth W; Guardiola J; Sinigaglia F
Nature; 1992 Apr; 356(6372):799-801. PubMed ID: 1574119
[TBL] [Abstract][Full Text] [Related]
16. Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells.
Fossum B; Gedde-Dahl T; Hansen T; Eriksen JA; Thorsby E; Gaudernack G
Eur J Immunol; 1993 Oct; 23(10):2687-91. PubMed ID: 7691613
[TBL] [Abstract][Full Text] [Related]
17. MHC-peptide binding: dimers of cysteine-containing nonapeptides bind with high affinity to HLA-A2.1 class I molecules.
Di Modugno F; Mammi C; Rosanò L; Rubiu O; Nisticò P; Chersi A
J Immunother; 1997 Nov; 20(6):431-6. PubMed ID: 9409448
[TBL] [Abstract][Full Text] [Related]
18. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes.
Jurewicz A; Biddison WE; Antel JP
J Immunol; 1998 Mar; 160(6):3056-9. PubMed ID: 9510211
[TBL] [Abstract][Full Text] [Related]
19. Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.
Nisini R; Romagnoli G; Gomez MJ; La Valle R; Torosantucci A; Mariotti S; Teloni R; Cassone A
Infect Immun; 2001 Jun; 69(6):3728-36. PubMed ID: 11349037
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
Kissick HT; Sanda MG; Dunn LK; Arredouani MS
PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
